Iiplatelet zingaphazanywanga nakwii-6 ezicetyiswayo umthamo we-osteoarthritis
Eli nqaku liyingxenye ye- Arthritis Archives.
Idatha: ngoFebruwari 20, 2000
Iiplatelet ezingaphazanyiswa yiCelebrex
Iziphumo ezivela kwiphando elilawulwa ngokuphindaphindiweyo, elingu-randomized, le-placebo elipapashwe kwincwadi ka-Februwari 2000 ye-Journal of Clinical Pharmacology ibonise ukuba i-arthritis yezidakamizwa iCelebrex (celecoxib) ayiphazamisi umsebenzi weplatelet nakwi-1200 mg / ngosuku.
I-dose ye-1200 mg / ngosuku ngokwenene amaxesha angama-6 ephakanyiswayo umthamo weCelebrex omiselwe unyango lwe- osteoarthritis.
Kutheni le nto yokufumana ukugcina umsebenzi oqhelekileyo weplatelet ibaluleke kakhulu? Kubalulekile:
- Izigulane ezisengozini yokukhupha igazi.
- Izigulane zithatha imishanguzo eyandisa ingozi yokuphuma kwamanzi.
- Abantu abane-arthritis abathabatha i-aspirin ye-dose ephantsi kwi-cardiovascular disease prophylaxis.
Malunga nesiFundo
Injongo yocwaningo yayikuthelekisa imiphumo yezinga eliphezulu kakhulu zeCelebrex kwizidakamizwa zokwelapha ze- naproxen kwiiplatelet.
- I-Celebrex yi- COX-2 inhibitor yokukhetha.
- I-Naproxen yi-NSAID engeyiyo ikhefu (izidakamizwa ezichasene nezidakamizwa).
Ngethuba leentsuku ezili-10, abathathi-nxaxheba abafundayo banikezwa ngokungafaniyo amanani ahlukeneyo:
- Celebrex
- naproxen
- i placebo
Izihlandlo zokuhlamba zazisetyenziselwa ukulinganisa umsebenzi weplatelet. Ngokwahlukileyo kwiCelebrex okanye indawo ye-placebo, i-naproxen yabonisa ukunciphisa ukuhlanganiswa kweplatelet kunye nokwandisa amaxesha okuphuma kwamanzi.
Inyaniso yokuba iCelebrex ayichange iphazamise ukutshatyalaliswa kweplatelet ngokuqhelekileyo kukuqinisekiswa ngakumbi kwe-COX-2 ukukhethwa kweziyobisi kunye nokukhuseleko kwayo.
I-Osteoarthritis Nezifo Zomzimba
Ngokuqhelekileyo i-osteoarthritis kunye nesifo senhliziyo sisenzeka kunye nabantu abadala. I-CDC (iZiko loLawulo lweNtsholongwane kunye noThintelo) liqikelele ukuba abantu abadala kwabangu-1 base-United States banomfutho wegazi kwaye bafika kwi-1 kubantu aba-3 abanomfutho wegazi ophezulu une-arthritis.
Malunga no-1 kwaba-5 abantu abangaphezu kweminyaka engama-35 ubudala bathabatha i- aspirin njengomlinganiselo wokuthintela isifo se-cardiovascular disease. Iziphumo zophando inkxaso yeCelebrex njengento ekhethekileyo yokukhetha abantu kwi-regimen ye-dose ephantsi.
Izixhobo ezinxulumene nazo
- Celebrex (celecoxib)
- Osteoarthritis
- I-COX-2 Inhibitors Ekhethiweyo
- Olongezelelweyo NgeeNSAID
Umthombo: Umbhalo we-Clinical Pharmacology, ngoFebhuwari 16, 2000, iMedscapeWire
Ukupapashwa kokuqala: 02/20/2000